NCT03066648 2025-05-18Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSNovartisPhase 1 Completed241 enrolled
NCT06034275 2024-11-15Study of VIP943 in Subjects With Advanced CD123+ Hematologic MalignanciesVincerx Pharma, Inc.Phase 1 Recruiting36 enrolled